Findings

What do systematic reviews say?

4 questions · 4 findings · 2 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 4 · 100%Moderate 0 · 0%High 0 · 0%

Adverse events · Patients with collagenous colitis

Budesonide showed no clear difference in adverse events compared with mesalazine (low certainty).

1 finding from 1 review

Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
RR 0.69 [0.43, 1.1]
1 study · 55 participants
Low

Adverse events · patients with active lymphocytic colitis

Budesonide showed no clear difference in adverse events compared with mesalazine (low certainty).

1 finding from 1 review

Interventions for treating lymphocytic colitis 2017 · Cochrane Headline outcomes only
RR 0.67 [0.12, 3.59]
1 study · 42 participants
Low

Serious adverse events · Patients with collagenous colitis

Budesonide showed no clear difference in serious adverse events compared with mesalazine (low certainty).

1 finding from 1 review

Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
RR 0.12 [0.01, 2.21]
1 study · 55 participants
Low

Withdrawals due to adverse events · Patients with collagenous colitis

Budesonide showed no clear difference in withdrawals due to adverse events compared with mesalazine (low certainty).

1 finding from 1 review

Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
RR 0.09 [0.01, 1.65]
1 study · 55 participants
Low